<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Design and analysis of bioavailability and bioequivalence studies</title>
  </titleInfo>
  <name type="personal">
    <namePart>Chow, Shein-Chung</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Liu, Jen-pei</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">flu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Boca Raton, Florida</placeTerm>
    </place>
    <publisher>CRC Press</publisher>
    <dateIssued>c2009</dateIssued>
    <dateIssued encoding="marc">2009</dateIssued>
    <edition>3rd ed.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xxii, 733 p. : ill. ; 25 cm.</extent>
  </physicalDescription>
  <tableOfContents>Design of bioavailability studies -- Statistical inferences for effects from a standard 2x2 crossover design -- Statistical methods for average bioequivalence -- Power and sample size determination -- Transformation and analysis of individual subject ratios -- Assessment of inter- and intra-subject variabilities -- Assumptions of outlier detection for average bioequivalence -- Optimal crossover designs for two formulations for average bioequivalence -- Assessment of bioequivalence for more than two formulations -- Population and individual bioequivalence -- Statistical procedures for assessment of population and individual bioequivalence -- Assessment of bioequivalence for drugs with negligible plasma levels -- In vitro bioequivalence testing -- In vitro dissolution profiles comparison -- Meta-analysis for bioequivalence review -- Population pharmacokinetics -- Other pharmacokinetic studies -- Review of regulatory guidances on bioequivalence -- Frequently asked questions and future challenges.</tableOfContents>
  <targetAudience authority="marctarget">specialized</targetAudience>
  <note type="statement of responsibility">Shein-Chun Chow, Jen-pei Liu</note>
  <note>Includes bibliographical references (p. 647-667) and index</note>
  <subject authority="lcsh">
    <topic>Bioavailability</topic>
    <topic>Research</topic>
    <topic>Statistical methods</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <topic>Therapeutic equivalency</topic>
    <topic>Research</topic>
    <topic>Statistical methods</topic>
  </subject>
  <relatedItem type="series">
    <titleInfo>
      <title>Chapman &amp; Hall/CRC biostatistics series ; 27</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">9781584886686</identifier>
  <identifier type="uri">http://www.loc.gov/catdir/toc/ecip0821/2008025461.html</identifier>
  <location>
    <url displayLabel="Table of contents only">http://www.loc.gov/catdir/toc/ecip0821/2008025461.html</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">UMP</recordContentSource>
    <recordCreationDate encoding="marc">100705</recordCreationDate>
    <recordChangeDate encoding="iso8601">20251117142456.0</recordChangeDate>
    <recordIdentifier source="KUKTEM">vtls000046973</recordIdentifier>
  </recordInfo>
</mods>
